
Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 3.130 | 3.130 | 0.000 |
Shares | 96.870 | 96.870 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 20.506 | 18.217 |
Price to Book | 5.930 | 3.356 |
Price to Sales | 2.994 | 2.188 |
Price to Cash Flow | 15.785 | 13.498 |
Dividend Yield | 2.678 | 2.930 |
5 Years Earnings Growth | 7.422 | 8.962 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 36.980 | 30.702 |
Industrials | 21.400 | 15.914 |
Consumer Defensive | 13.420 | 12.677 |
Financial Services | 11.840 | 21.709 |
Basic Materials | 9.950 | 8.201 |
Consumer Cyclical | 4.550 | 5.298 |
Technology | 1.850 | 3.448 |
Number of long holdings: 23
Number of short holdings: 0
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Nestle | CH0038863350 | 13.00 | 83.21 | +9.30% | |
Roche Holding Participation | CH0012032048 | 11.54 | 285.30 | +0.42% | |
Novartis | CH0012005267 | 10.95 | 104.34 | +0.29% | |
Zurich Insurance Group | CH0011075394 | 7.80 | 558.80 | -3.05% | |
ABB | CH0012221716 | 6.72 | 59.18 | -0.64% | |
Lonza Group | CH0013841017 | 6.58 | 548.20 | +2.12% | |
Givaudan | CH0010645932 | 5.52 | 3,539.00 | +2.82% | |
Belimo Holding | CH1101098163 | 4.42 | 807.0 | +0.88% | |
Sika | CH0418792922 | 4.12 | 176.55 | +0.54% | |
Partners Group | CH0024608827 | 3.67 | 1,002.00 | -0.69% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
BCV PENSION 25 AP | 944.42M | 1.80 | 5.38 | 2.22 | ||
BCV PENSION 40 AP | 673.26M | 2.87 | 6.87 | 3.74 | ||
Synchrony All Caps CH I | 581.61M | 2.52 | 4.66 | 7.52 | ||
Synchrony Small Mid Caps CH I | 175.47M | 3.45 | 4.70 | 7.64 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review